On August 19, 2014, the US Food and Drug Administration (hereinafter referred to as FDA) approved 3D printing services company OPM (Oxford Performance Materials) 3D printing OsteoFab specific patient facial device (hereinafter referred to as OPSFD) obtained market license.
Prior to this, OPM's OsteoFab Patient Specific Skull Device (OPSCD) received an FDA's 510(k) market access permit in 2013. The skull device and the OPSFD use the same printing materials. OPSFD uses a combination of OsteoFab technology for laser sintering and additive technology, and uses the EOSINT P 800 printer and OPM's polyetherketoneketone (PEKK) polymer to print during the printing process. These techniques and facial materials and facials are made from printed materials. Histocompatibility does not cause any discomfort.
For OPSFD to be admitted to the market, OPM officials said that there is currently no truly personalized and cost-effective medical solution in the field of facial reconstruction, and the FDA's approval of OPM's latest market access for orthopaedic implant products marks facial reconstruction. The coming of a new era.
Facial implant
The application of OPM technology in the medical industry is especially the biggest feature. First, reduce time and improve work efficiency. Second, realize personalized customization of face implants and save costs. At the same time as its promotion of OPSFD, Biomet, as a leading supplier in the medical field, has undoubtedly become the exclusive distributor of OPSFD.
Olive Net Problems,Olive Net Packages,Olive Net Network,Olive Harvest Net
Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejt.com